tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jeet Mukherjee, 32 are a BUY (96.97%), 1 are a HOLD (3.03%).
Analyst Jeet Mukherjee, currently employed at BTIG, carries an average stock price target met ratio of 19.05% that have a potential upside of 19.52% achieved within 60 days.
Jeet Mukherjee’s has documented 63 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NRIX, Nurix Therapeutics at 10-Jul-2026.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 9/9/2025. The price target of $87 was fulfilled within 23 days with a profit of $42.07 (93.63%) receiving and performance score of 40.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2024
$18
$9.97 (124.16%)
$15
Buy Since 05-Mar-2026
$24
$15.97 (198.88%)
$21
Buy Since 02-May-2025
$16
$7.97 (99.25%)
$14
Buy Since 22-Oct-2018
$20
$11.97 (149.07%)
Hold Since 18-Sep-2025
$11
$2.97 (36.99%)
$9
Which stock is Jeet Mukherjee is most bullish on?
Which stock is Jeet Mukherjee is most reserved on?
What Year was the first public recommendation made by Jeet Mukherjee?
